Oncoematologia Notizia Notizia Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis 31.10.2024 Forty-eight consecutive Hodgkin lymphoma (HL) patients staged with [18F] fluorodeoxyglucose positron emission tomography/computed tomography were...
Oncoematologia Notizia Notizia MRI-based bone marrow radiomics for predicting cytogenetic abnormalities in multiple myeloma 31.10.2024 Patients with newly diagnosed MM were enrolled retrospectively from March 2019 to September 2022. They were categorised into the high-risk...
Oncoematologia Articolo scientifico Measurable Residual Disease and Decision-Making in Multiple Myeloma 29.10.2024 Measurable (minimal) residual disease (MRD) has already proven to be one of the most important prognostic factors in multiple myeloma (MM).
Articolo scientifico Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype… 29.10.2024 Linear IgA bullous dermatosis (LABD) is a rare autoimmune bullous disease that results in subepidermal blisters with an infiltration of neutrophils...
Notizia Notizia Uses and limitations of small-volume biopsies for the diagnosis of lymphoma 29.10.2024 It is important for pathologists and clinicians to recognize both the strengths and limitations of such biopsies.
Oncoematologia Notizia Notizia A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in… 29.10.2024 Multiple myeloma (MM) is a distinguished hematologic malignancy, with existing studies elucidating its interaction with neutrophil extracellular traps...
Oncoematologia Articolo scientifico Immune-Pathogenesis of Myeloma 28.10.2024 This research indicates that monoclonal gammopathy of undetermined significance (MGUS) and myeloma may stem from chronic immune activation and...
Oncoematologia Notizia Notizia An inflammatory response-related gene signature can predict the prognosis and impact the immune infiltration of multiple… 28.10.2024 Multiple myeloma (MM) is a highly heterogeneous and incurable disease. Inflammation plays a vital role in cancer genesis and progression.
Oncoematologia Articolo scientifico Impact of Clonal Heterogeneity in Multiple Myeloma 24.10.2024 Multiple myeloma is characterized by a highly heterogeneous disease distribution within the bone marrow-containing skeletal system.
Oncoematologia Articolo scientifico Psychological care over patients with lymphoma and lymphoma survivors 24.10.2024 There is insufficient evidence on the efficacy of psychological interventions for lymphoma patients. This review aimed to present the research...
Notizia Notizia Peripheral T cell lymphoma initially presenting in lung biopsies: A diagnostic challenge 24.10.2024 Primary or secondary pulmonary involvement by peripheral T cell lymphoma (PTCL) is rare and difficult to diagnose particularly via lung biopsies.
Oncoematologia Notizia Notizia Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma 24.10.2024 RDW is an erythrocyte index that increase in multiple myeloma, in which it appears to have an important role in predicting outcome.
